Related Experiment Video

Updated: May 22, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.7K

Therapeutic perspectives for recurrent or metastatic head and neck squamous cell carcinoma

Thibault Gauduchon1, Eve Marie Neidhardt, Jerome Fayette

  • 1Centre Léon Bérard, Lyon, France.

Current Opinion in Oncology
|March 12, 2025
PubMed
Abstract

Insights

Novel therapies, including immunotherapy combinations and antibody-drug conjugates (ADCs), show promise for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). These approaches aim to overcome resistance and improve patient outcomes in this challenging cancer.

Area of Science:

  • Oncology
  • Head and Neck Cancer Research
  • Translational Medicine

Background:

  • Recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) presents significant therapeutic challenges.
  • Biological complexity and clinical heterogeneity contribute to poor patient outcomes.
  • There is a persistent unmet need for effective treatment strategies.

Purpose of the Study:

  • To review novel therapeutic approaches for R/M HNSCC.
  • To highlight recent advances in treatment strategies.
  • To address the unmet needs in patient outcomes for R/M HNSCC.

Main Methods:

  • Review of recent phase II and III clinical trials.
  • Analysis of emerging therapeutic strategies.
  • Synthesis of findings on novel treatment modalities.

Main Results:

  • Promising strategies include immunotherapy combinations, antibody-drug conjugates (ADCs), HPV vaccines, dual immunotherapy, and tumor microenvironment-targeting therapies.
  • These innovations aim to overcome treatment resistance mechanisms.
  • Emerging directions focus on improving treatment efficacy in R/M HNSCC.

Conclusions:

  • Integrating innovative strategies like ADCs and immunotherapy combinations may enhance clinical outcomes for R/M HNSCC.
  • Targeting the tumor microenvironment is a key emerging strategy.
  • Further research is crucial to refine and optimize these novel therapies for clinical practice.
Keywords:
HPV-targeted therapiesantibody–drug conjugatesimmunotherapyrecurrent or metastatic head and neck squamous cell carcinomatargeted therapy

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.4K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

242

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
319
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K